Startup Ideas Bank
Automating pre-auth for radiology/oncology: a profitable SaaS play with clear enterprise value.
AI roast score: 82/100 (A-)
The idea
This isn't a startup, it's a mini-empire. $9.1M ARR, 380 hospitals, $18M Series A. They've cracked the code on B2B healthcare SaaS, now they're going global. Watch out, incumbents.
The roast
Let's be clear, this isn't an 'idea' anymore, it's a functioning, profitable business. The notion of roasting a company with $9.1M ARR and a Series A is almost laughable. You've clearly identified a massive pain point in healthcare administration – the pre-authorization quagmire – and built a solution that hospitals are willing to pay handsomely for, year after year. The fact that you're already profitable before this funding round speaks volumes about your execution and product-market fit. The average deal size of $24k per facility for enterprise hospital systems is solid, indicating a clear understanding of buyer value and willingness to pay. The only 'roast' I can offer is that your biggest challenge is now scale and internationalization, which, while complex, is a good problem to have. Complaining about HIPAA and state compliance as you expand globally is like a seasoned marathon runner worrying about a slight incline. It's the next logical hurdle, not a fundamental flaw in your race strategy. You've built the engine; now you just need to map the new territories.
Red flags
- International compliance complexity: While a good problem, it's a significant operational and legal hurdle that could sl
- Enterprise sales cycle length: Selling to hospital networks is notoriously slow; scaling internationally could exacerbat
- Reliance on existing hospital IT infrastructure: Integration challenges or compatibility issues could arise with diverse
Verdict
You've built a robust, profitable enterprise SaaS business in a high-friction industry; focus on executing your international expansion with the same rigor you've shown domestically.